Last reviewed: June 15, 2026
Last updated: June 15, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 agonists represent a major advancement in weight management science. These medications work by activating receptors in your brain that regulate appetite, blood sugar, and energy use—helping you feel fuller longer and eat less naturally. PlexusDx makes this proven therapy accessible with compounded options tailored to your body's unique peptide pathways.
How Do GLP-1 Agonists Work in Your Body?
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces when you eat. This hormone signals your pancreas to release insulin, slows stomach emptying, and tells your brain you're satisfied—all mechanisms that help control blood sugar and appetite. GLP-1 agonist medications amplify these signals, making your body behave as though you've eaten more than you actually have, which leads to reduced calorie intake without willpower-dependent restriction.
When you take a GLP-1 medication like semaglutide, it binds to GLP-1 receptors found throughout your brain, stomach, and pancreas. This activation triggers a cascade of effects: your appetite decreases, food cravings weaken, and your metabolic rate may slightly increase. Clinical studies show that people using GLP-1 agonists typically lose 10-15% of their body weight over six months to one year, with benefits extending to improved blood sugar control and reduced cardiovascular risk.
Semaglutide vs. Other GLP-1 Medications: Key Differences
Semaglutide is a long-acting GLP-1 agonist designed to work for seven days after a single injection, meaning you only need one dose per week. This extended action makes it easier to stick with treatment compared to daily medications. Semaglutide has been extensively studied in large trials like STEP, which demonstrated sustained weight loss and improved metabolic markers in over 4,600 participants across multiple studies.
Other GLP-1 options include tirzepatide, which targets both GLP-1 and GIP receptors for potentially stronger appetite suppression, and oral formulations that offer an injection-free alternative. PlexusDx offers compounded semaglutide injections starting at $149/month, compounded tirzepatide injections from $249/month, and oral versions of both for those preferring non-injection delivery. Your PlexusDx provider helps match you with the right compound and dose based on your health profile and goals.
Why Compounded GLP-1 Medications Cost Less Than Brand Names
Brand-name GLP-1 medications like Ozempic and Mounjaro can cost $900 to $1,500+ per month without insurance. Compounded versions provide the same active pharmaceutical ingredients—manufactured in licensed 503A compounding pharmacies under strict FDA oversight—at a fraction of the price. PlexusDx's compounded semaglutide injection starts at just $149/month, and all pricing remains flat regardless of dose increases, meaning your medication stays affordable as your treatment progresses.
Compounding allows pharmacy teams to prepare customized doses tailored to your body's response, reducing waste and passing savings directly to patients. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization delays. HSA and FSA accounts are accepted, making compounded GLP-1 therapy an accessible option for weight loss that doesn't drain your budget.
Personalized GLP-1 Treatment Through Genetic Testing
Not everyone responds equally to GLP-1 therapy, and part of that variation comes from your genetics. Certain genetic variants in the GLP1R gene (like rs6923761), the GIPR receptor (rs1800437), and appetite-regulation genes (FTO rs9939609, MC4R rs17782313) influence how effectively you respond to GLP-1 agonists and which compounds may work best for you. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways across 49 peptides and 150+ genetic insights to identify your unique response profile.
This genetic roadmap helps PlexusDx providers optimize your treatment from the start, potentially improving results and reducing trial-and-error dosing. The Precision Peptide Test is available as a $99 add-on after your first month of treatment, giving your provider data to fine-tune your compound, dose, or even recommend a dual-therapy option like GLP-Squared (combining semaglutide and tirzepatide) if your genetic profile suggests it would benefit you more than a single agent.
Safety, Side Effects, and What to Expect
GLP-1 agonists are generally well-tolerated, with the most common side effects being nausea, vomiting, and constipation—especially in the first few weeks as your body adjusts. These effects typically improve as your body adapts, and starting with a lower dose and increasing gradually (dose titration) helps minimize discomfort. Serious side effects are rare and include pancreatitis or severe allergic reactions; patients with a personal or family history of medullary thyroid cancer should avoid GLP-1 therapy.
Dehydration is a concern with GLP-1 use because reduced appetite can lead to lower fluid intake, so staying hydrated and maintaining adequate nutrition is essential. Women who are pregnant or planning to become pregnant should discuss GLP-1 use with their provider, as these medications should typically be stopped before conception. PlexusDx providers screen for contraindications and monitor your progress throughout treatment, adjusting your dose and compound as needed to maximize safety and results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the difference between a GLP-1 agonist and a GLP-1 receptor agonist?
These terms are used interchangeably. Both refer to medications that bind to and activate GLP-1 receptors in your brain and body. The word 'agonist' simply means the drug activates the receptor rather than blocking it, triggering the appetite and metabolism signals that help with weight loss.
How quickly will I see weight loss results with a GLP-1 agonist?
Most people notice reduced appetite and early weight loss within 2-4 weeks of starting a GLP-1 agonist like semaglutide. Significant weight loss typically becomes visible over 8-12 weeks, with maximum benefits often reached at 6-12 months. Individual results vary based on genetics, diet, exercise, and adherence to treatment.
Why does PlexusDx say 'Your dose may go up, but your price won't'?
PlexusDx charges one flat monthly price for each medication regardless of dose level. With compounded semaglutide starting at $149/month, your cost remains $149 whether your provider increases your dose from 0.25 mg to 2.4 mg—eliminating the hidden cost escalation seen with other providers and brand-name options.
Are compounded GLP-1 medications as safe as brand-name versions?
Yes. PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which operate under FDA oversight and follow strict pharmaceutical standards. The active ingredients are identical to brand names; the difference is lower cost through efficient compounding rather than mass pharmaceutical manufacturing and marketing expenses.
How does the Precision Peptide Genetic Test help my GLP-1 treatment?
The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R genes—all key regulators of appetite and metabolism. PlexusDx uses these insights across 14 pathways to predict which GLP-1 compound, dose, or dual-therapy approach will likely work best for your unique body, improving results and speeding up the optimization process.
Can I use my HSA or FSA to pay for PlexusDx GLP-1 therapy?
Yes. PlexusDx GLP-1 medications and the Precision Peptide Genetic Test are both HSA and FSA eligible, allowing you to use pre-tax health savings to cover costs. This can reduce your out-of-pocket expense significantly compared to paying with after-tax dollars.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Semaglutide: What Not to Take for a Safer Weight Loss Journey
Can I Eat Pizza on Ozempic? Navigating Your Diet on GLP-1 Medications